Compare PSNL & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PSNL | FRGE |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 746.8M | 618.2M |
| IPO Year | 2019 | N/A |
| Metric | PSNL | FRGE |
|---|---|---|
| Price | $7.88 | $44.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 4 |
| Target Price | $11.17 | ★ $31.00 |
| AVG Volume (30 Days) | ★ 1.4M | 131.7K |
| Earning Date | 02-26-2026 | 03-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $69,103,000.00 | ★ $92,884,000.00 |
| Revenue This Year | N/A | $33.10 |
| Revenue Next Year | $19.41 | $24.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 16.40 |
| 52 Week Low | $2.83 | $6.60 |
| 52 Week High | $11.50 | $44.88 |
| Indicator | PSNL | FRGE |
|---|---|---|
| Relative Strength Index (RSI) | 40.44 | 57.23 |
| Support Level | $7.27 | $44.50 |
| Resistance Level | $9.79 | $44.70 |
| Average True Range (ATR) | 0.86 | 0.10 |
| MACD | -0.28 | -0.10 |
| Stochastic Oscillator | 14.89 | 24.00 |
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.